Parkinson: a collaboration for the benefit of therapeutic acceleration
All the news from Servier Group
Servier, 2nd sponsor of the ESC 2021 Congress!
Servier and OSE Immunotherapeutics announce enrollment of first patient in Phase 2 Clinical Trial in Sjögren’s Syndrome
Shanghai ranking: Paris-Saclay University has risen to 13th place!
Servier commits to the preservation of forests with Planète Urgence
Neuroscience: new research partnership for Servier
Mécénat Servier partners with three new associative projects!
Servier partners with BioLabs to open an incubator in Paris-Saclay for early stage life science start-ups
Olivier Laureau confirmed as Second Vice President of EFPIA